LEGAL

Legal Statement
GALDERMA LABORATORIES, L.P. IMPORTANT LEGAL INFORMATION
Copyright 2012 Galderma Laboratories, L.P.
P.O. Box 331329
Fort Worth, Texas 76163-1329

All use of the Epiduo® Gel website is subject to the terms and conditions set forth below. Any use of such Web pages constitutes the user's agreement to abide by the following terms and conditions.

Galderma Epiduo® Gel Web pages are designed for educational purposes only. This information is not intended to substitute for informed medical advice. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Galderma Laboratories, L.P. does not endorse or attest to the validity or accuracy of any treatments, medications, or non-Galderma products discussed herein. Before acting on any information contained on the Web pages, you agree that you will consult your healthcare provider to determine whether the information you are relying on is appropriate for your medical conditions.

All information provided by Galderma is owned by or licensed to Galderma. Galderma and its licensors retain all proprietary rights to the information contained on the pages. Except for making one hard copy print of the information or downloading the material for a one-time use, information on the pages may not be reproduced, transmitted, distributed, or displayed, without the express consent of Galderma.

THIS WEBSITE IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. THIS WEBSITE COULD INCLUDE TECHNICAL INACCURACIES OR TYPOGRAPHICAL ERRORS. CHANGES ARE PERIODICALLY ADDED TO THE INFORMATION HEREIN; THESE CHANGES WILL BE INCORPORATED IN NEW EDITIONS OF THE WEBSITE.

GALDERMA MAY MAKE IMPROVEMENTS AND/OR CHANGES IN THE PRODUCT(S) AND/OR THE PROGRAM(S) DESCRIBED IN THIS WEBSITE AT ANY TIME.

For further intellectual property information regarding the Galderma Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% website, please contact webmaster@galderma.com.

© 2012 GALDERMA LABORATORIES, L.P. United States

Track your progress

Get the mobile app

Help your teen take action

Make a plan

Get the doctor discussion guide

Download the PDF

You could pay no more than $35*
and download the Blame Biology kit

Learn more

Important Safety Information
Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warning/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

* Insured patients could pay no more than $35 for their Epiduo® Gel prescription (for one tube or pump, after primary insurance and the Epiduo Gel Instant Advantage Card). Restrictions may apply.

©2012 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information

Close

Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

TWITTER FACEBOOK EMAIL
Close

SHARE THE NEWS

All fields are required.

Your Email Address:

Your Name:

Recipient's Email Address:

Send me a copy of this email

View our Privacy Policy